We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+24.68%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.51B
AUM Growth
+$758M
Cap. Flow
+$605M
Cap. Flow %
17.25%
Top 10 Hldgs %
47.4%
Holding
285
New
108
Increased
67
Reduced
35
Closed
69

Top Buys

Rank Stock Value
1
IMDX
Insight Molecular Diagnostics
IMDX
+$28.2M
2
ALGN icon
Align Technology
ALGN
+$19.3M
3
APR
Apria, Inc. Common Stock
APR
+$17.3M
4
CUTR
Cutera, Inc.
CUTR
+$14.8M
5
CMIIU
CM Life Sciences II Inc. Unit
CMIIU
+$13M

Top Sells

Rank Stock Value
1
VCEL icon
Vericel Corp
VCEL
+$14.4M
2
AFIB
Acutus Medical Inc
AFIB
+$13.5M
3
SHC icon
Sotera Health
SHC
+$12.9M
4
OPCH icon
Option Care Health
OPCH
+$12.1M
5
BNGO icon
Bionano Genomics
BNGO
+$10.3M

Sector Composition

Rank Sector Weight
1 Healthcare 33%
2 Industrials 1.49%
3 Materials 0.46%
4 Financials 0.45%
5 Consumer Staples 0.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GH icon
226
CALL
Guardant Health
GH
$22.2B
– –
-20,000
Closed -$2.58M
GILD icon
227
CALL
Gilead Sciences
GILD
$168B
– –
-200,000
Closed -$11.7M
HAE icon
228
Haemonetics
HAE
$4.16B
– –
-82,500
Closed -$9.8M
IHF icon
229
PUT
iShares US Healthcare Providers ETF
IHF
$1.27B
– –
-775,000
Closed -$36.4M
IHI icon
230
PUT
iShares US Medical Devices ETF
IHI
$3.48B
– –
-780,000
Closed -$42.5M
ILMN icon
231
CALL
Illumina
ILMN
$29.1B
– –
-41,120
Closed -$14.8M
IMVT icon
232
Immunovant
IMVT
$8.8B
– –
-118,702
Closed -$5.48M
IRTC icon
233
PUT
iRhythm Holdings
IRTC
$4.13B
– –
-55,000
Closed -$13M
JETS icon
234
CALL
US Global Jets ETF
JETS
$825M
– –
-1,000,000
Closed -$22.4M
KIDS icon
235
OrthoPediatrics
KIDS
$649M
– –
-145,440
Closed -$6M
KROS icon
236
Keros Therapeutics
KROS
$222M
– –
-5,000
Closed -$353K
LH icon
237
PUT
Labcorp
LH
$26.2B
– –
-17,460
Closed -$3.05M
LLY icon
238
CALL
Eli Lilly
LLY
$1.09T
– –
-100,000
Closed -$16.9M
MDT icon
239
CALL
Medtronic
MDT
$116B
– –
-200,000
Closed -$23.4M
NKTR icon
240
CALL
Nektar Therapeutics
NKTR
$2.57B
– –
-13,333
Closed -$3.4M
NKTR icon
241
Nektar Therapeutics
NKTR
$2.57B
– –
-5,140
Closed -$1.31M
OPCH icon
242
Option Care Health
OPCH
$3.57B
– –
-775,000
Closed -$12.1M
PEN icon
243
PUT
Penumbra
PEN
$12.9B
– –
-20,000
Closed -$3.5M
PRFX icon
244
PRF Technologies Ltd
PRFX
$3.13M
– –
-8
Closed -$45K
QDEL icon
245
PUT
QuidelOrtho
QDEL
$1.02B
– –
-45,000
Closed -$8.08M
QGEN icon
246
PUT
Qiagen
QGEN
$8.88B
– –
-70,729
Closed -$3.96M
RGEN icon
247
Repligen
RGEN
$9.35B
– –
-25,000
Closed -$4.79M
SENS icon
248
CALL
Senseonics Holdings Inc
SENS
$419M
– –
-50,000
Closed -$872K
SENS icon
249
Senseonics Holdings Inc
SENS
$419M
– –
-97,500
Closed -$1.7M
SHC icon
250
Sotera Health
SHC
$5.39B
– –
-471,000
Closed -$12.9M
8 9
10
11 12

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2021 Portfolio in Review

As of Q1 2021, Pura Vida Investments held 285 positions worth $3.51B, up 28% from $2.75B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Pura Vida Investments deployed $605M of net new capital in Q1 2021, opening 108 new positions and adding to 67 existing holdings. Its largest new stake was Align Technology: 35,000 shares worth $19M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Industrials and Materials.

On the sell side, the largest reduction was Vericel Corp, an estimated $14.4M trimmed.

  • Pura Vida Investments's largest Q1 2021 buy was Align Technology: 35,000 shares worth $19M.
  • Pura Vida Investments added most to Insight Molecular Diagnostics in Q1 2021, an estimated $28.2M increase.
  • Pura Vida Investments's biggest Q1 2021 reduction was Vericel Corp, cutting an estimated $14.4M.
  • Pura Vida Investments fully exited Acutus Medical Inc in Q1 2021, selling an estimated $13.5M.
  • Pura Vida Investments's ten largest holdings make up 47% of its $3.51B portfolio in Q1 2021.
  • Pura Vida Investments opened 108 new positions and closed 69 in Q1 2021.
  • Pura Vida Investments's portfolio value rose 28% quarter-over-quarter to $3.51B.

Based on Pura Vida Investments's 13F filing for Q1 2021, filed 12 May 2021.